Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. - Wikidata - wikimedia - TriplyDB

Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.

Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.

http://www.wikidata.org/entity/Q34215250

about

Burns: an update on current pharmacotherapy The Burn Wound Microenvironment Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models Disruption of bone and skeletal muscle in severe burns Physical rehabilitation of pediatric burns A Novel Drug-Mouse Phenotypic Similarity Method Detects Molecular Determinants of Drug Effects Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.Nutrition and metabolism in burn patients.Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases The role of exercise in the rehabilitation of patients with severe burns.Predictors of muscle protein synthesis after severe pediatric burns Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.Long-term propranolol use in severely burned pediatric patients: a randomized controlled study.Exercise training after burn injury: a survey of practice.The surgically induced stress response.Is propranolol of benefit in pediatric burn patients?Practice Guidelines for Cardiovascular Fitness and Strengthening Exercise Prescription After Burn Injury.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.The metabolic stress response to burn trauma: current understanding and therapies.Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.The P50 Research Center in Perioperative Sciences: How the investment by the National Institute of General Medical Sciences in team science has reduced postburn mortality.Improving Research Enrollment of Severe Burn Patients.Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients.35ème congrès SFB, table ronde «nutrition»: transcription des communications.Early Enteral Nutrition for Burn Injury.Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children.The Role of Bone Secreted Factors in Burn-Induced Muscle Cachexia.Chronic Critical Illness: Application of What We Know.Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.Alcohol Modulation of the Postburn Hepatic Response.Interactions of Phosphate Metabolism With Serious Injury, Including Burns The Long-Term Impact of Severe Burn Trauma on Musculoskeletal Health

P2860

Q24618730-D06F8F9C-555B-40FC-865C-C51F8AC9B6AC Q26753839-892F2B61-890F-4739-8A36-BEE22132F5D3 Q26771250-BBCBCC15-9A9F-4474-AFD0-B17EBE45CA47 Q26798177-B59FBA57-28DB-4AE9-9019-B2010A14598B Q26827374-2463A08F-7CE9-4F87-BC18-45C99C417043 Q28554371-6352506B-39B8-4480-BE2A-3B20C675371E Q30490969-6031B7C2-C985-4582-833A-F0E6A89E18C0 Q33568722-27EA0E69-F4C7-4EF6-8FF0-1D7E86469324 Q34145591-1F7B38AF-E809-4A06-9345-AC9872E23375 Q34747041-A04F3AF4-DAB3-4D04-8DEE-3B6208FFC876 Q35222745-31EABDD0-F8E3-4611-AAB8-CEB5AE2913CD Q35561653-58FC387E-B16C-481F-AEBF-B2BAA2AD6E8E Q35743964-EFBF900D-056A-4956-B4C6-9F1A12144FD8 Q35822989-937BCC72-3862-4045-B6B2-85A3861F72FA Q36422015-DA49B036-14A6-46D0-8727-EB100EA27905 Q36948234-B0A2ACCF-1288-4F47-BC80-0B55F97D5237 Q37577359-16576B07-3998-482C-873C-B01E832F4993 Q37640359-EE8E31AE-E05B-4FE0-A379-C0C7FB81B34D Q38568932-2B027B9A-0F86-4A77-8C68-67EEF444054D Q38751931-EA5777F2-7850-4DFB-877D-E34608E01E92 Q38935716-52322EF3-893B-456B-B5B4-DA07D8FE271C Q38972966-377A06AD-8A2A-4588-8AA5-59FB445F79AA Q39351365-B36FB474-1B8F-4A3D-9C9B-CCBA76B6CAF1 Q39428637-3CE19A6B-678E-4C66-9F31-B7243334BEF9 Q40067903-3F22BF22-5792-4727-9926-3644C6E565AE Q41036080-815BA3E4-CC6B-44B9-88B3-18C7F7CC16D2 Q41492942-6C63394D-95E1-4C88-B2F1-CD9B24BBA071 Q42736081-8F56C3A1-C835-4306-94FF-477A0125A01A Q47639994-058DB3D4-C1F4-4646-B5CC-C0B04C68E518 Q49980475-7ACC5DD1-3B8D-4F54-A701-F0BE15501CDD Q50091197-ACB8F076-711E-4E3C-83D5-189F4DE422BE Q51150459-296F8C76-59D5-44C8-805C-7CE5EBFEEFB4 Q53967982-93251D0B-E34F-407E-A210-76079BD31903 Q57152961-84DA9FCF-8055-4D60-A0B8-61FC5B87B282 Q57797690-BFDDBD38-D4DD-40F2-AC1A-206C61B27055

P2860

Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.

http://www.wikidata.org/entity/Q34215250

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Five-year outcomes after oxand ...... trial of safety and efficacy.

@ast

Five-year outcomes after oxand ...... trial of safety and efficacy.

@en

Five-year outcomes after oxand ...... trial of safety and efficacy.

@nl

type

label

Five-year outcomes after oxand ...... trial of safety and efficacy.

@ast

Five-year outcomes after oxand ...... trial of safety and efficacy.

@en

Five-year outcomes after oxand ...... trial of safety and efficacy.

@nl

prefLabel

Five-year outcomes after oxand ...... trial of safety and efficacy.

@ast

Five-year outcomes after oxand ...... trial of safety and efficacy.

@en

Five-year outcomes after oxand ...... trial of safety and efficacy.

@nl

P1433

Q34215250-8839BBB7-F64E-4730-AE49-F792C24D944A

P1476

Q34215250-8063B7C6-3C6D-4FBB-ACCD-DFC83B8EDA22

P2093

Q34215250-31ABC184-FDBC-45CA-889D-7D1C8D38BFAC

Q34215250-5E2653AD-F631-475C-9033-2660AD3C3D6D

Q34215250-67F19AC2-A824-402D-A8D3-947B1E4A8D97

Q34215250-6C15B9CB-95BB-4CC6-B382-FE56CCC426ED

Q34215250-981B1432-7019-4C7C-9D5C-2181372DDC29

Q34215250-A74C9917-858F-4C3F-B527-7EFDEE312E75

Q34215250-A8F0CD84-B8F5-4C41-A78C-1570E4150E81

Q34215250-B1099585-4570-43FF-B154-711E799C339D

Q34215250-F0C5B83A-62A5-4F4F-A666-81DE0B9BF3AE

Q34215250-F8409063-2A72-4B50-AC86-F5B62DC818D5

P2860

Q34215250-047D47DD-CB00-4E23-8072-0C5D5F0ED886

Q34215250-107619C0-EB62-4E15-8998-079E9DFDA368

Q34215250-10C56596-248C-44E3-BFFF-93F3755E6A2E

Q34215250-113A9B4D-9EA8-489D-9611-250541FE7DD8

Q34215250-11E964B2-20A7-4199-B4F3-4259322BB43F

Q34215250-14CBF355-93CD-4B9C-8DF0-3FF3BAA6AF60

Q34215250-190285F1-FAA4-4241-A90B-714FEE7E5A20

Q34215250-19640375-8D0E-4037-AE00-4606A4CB47D6

Q34215250-1A997704-05AE-4049-9E4A-143834C83BCA

Q34215250-2104DB42-CF74-4964-8CFF-2D9DE9F86B30

P304

Q34215250-BC9B77D4-754A-41C1-A29B-44D511F42D9C

P31

Q34215250-8F989AED-A463-4B21-B914-FBB7577CE71D

P356

Q34215250-F47B29CB-B4D9-4B95-9517-EC1D2E6D98EF

P433

Q34215250-08A1022A-7707-4190-857D-65D503F823A2

P478

Q34215250-8203F1F2-F1C4-4213-A002-A2898B7A642A

P577

Q34215250-9AAB6774-1345-432C-95A1-A04B23F12901

P5875

Q34215250-BD37C02C-ECCA-4A29-8E9F-D39D2FB8989E

P698

Q34215250-D2BE3E4D-57D3-4053-A88D-07A7494C6277

P932

Q34215250-0E604425-DDDA-4478-AC6E-22B9B11C99F6

P356

J.JAMCOLLSURG.2011.12.038

P1433

Journal of the American College of Surgeons

P1476

Five-year outcomes after oxand ...... trial of safety and efficacy.

@en

P2093

Celeste C Finnerty

http://www.w3.org/2001/XMLSchema#string

David N Herndon

http://www.w3.org/2001/XMLSchema#string

Gordon L Klein

http://www.w3.org/2001/XMLSchema#string

Jong O Lee

http://www.w3.org/2001/XMLSchema#string

Kristofer Jennings

http://www.w3.org/2001/XMLSchema#string

Laura J Porro

http://www.w3.org/2001/XMLSchema#string

Noe A Rodriguez

http://www.w3.org/2001/XMLSchema#string

Oscar E Suman

http://www.w3.org/2001/XMLSchema#string

Ronald P Mlcak

http://www.w3.org/2001/XMLSchema#string

Walter J Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Anabolic effects of oxandrolone after severe burn

The effects of oxandrolone and exercise on muscle mass and function in children with severe burns

The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn

CDC growth charts: United States

Effects of long-term oxandrolone administration in severely burned children.

The effect of oxandrolone treatment on human osteoblastic cells.

Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.

Pathophysiologic response to severe burn injury.

Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis.

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting

P304

489-502; discussion 502-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAMCOLLSURG.2011.12.038

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223992500

http://www.w3.org/2001/XMLSchema#string

P698

22463890

http://www.w3.org/2001/XMLSchema#string

P932

3412530

http://www.w3.org/2001/XMLSchema#string